← Back to opportunities
grant
National Institutes of Health

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Source: grants.gov CFDA: Status: forecasted Lifecycle: new

Eligibility

See opportunity for details

Similar opportunities